Literature DB >> 23320295

Crucial factors and emerging concepts in ultrasound-triggered drug delivery.

Bart Geers1, Heleen Dewitte, Stefaan C De Smedt, Ine Lentacker.   

Abstract

Time and space controlled drug delivery still remains a huge challenge in medicine. A novel approach that could offer a solution is ultrasound guided drug delivery. “Ultrasonic drug delivery” is often based on the use of small gas bubbles (so-called microbubbles) that oscillate and cavitate upon exposure to ultrasound waves. Some microbubbles are FDA approved contrast agents for ultrasound imaging and are nowadays widely investigated as promising drug carriers. Indeed, it has been observed that upon exposure to ultrasound waves, microbubbles may (a) release the encapsulated drugs and (b) simultaneously change the structure of the cell membranes in contact with the microbubbles which may facilitate drug entrance into cells. This review aims to highlight (a) major factors known so far which affect ultrasonic drug delivery (like the structure of the microbubbles, acoustic settings, etc.) and (b) summarizes the recent preclinical progress in this field together with a number of promising new concepts and applications.

Mesh:

Substances:

Year:  2012        PMID: 23320295     DOI: 10.1016/j.jconrel.2012.08.014

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  23 in total

Review 1.  Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.

Authors:  Nazila Kamaly; Basit Yameen; Jun Wu; Omid C Farokhzad
Journal:  Chem Rev       Date:  2016-02-08       Impact factor: 60.622

Review 2.  Advances in Biomaterials for Drug Delivery.

Authors:  Owen S Fenton; Katy N Olafson; Padmini S Pillai; Michael J Mitchell; Robert Langer
Journal:  Adv Mater       Date:  2018-05-07       Impact factor: 30.849

3.  Single-site sonoporation disrupts actin cytoskeleton organization.

Authors:  Xian Chen; Ruen Shan Leow; Yaxin Hu; Jennifer M F Wan; Alfred C H Yu
Journal:  J R Soc Interface       Date:  2014-03-26       Impact factor: 4.118

Review 4.  The present and future role of ultrasound targeted microbubble destruction in preclinical studies of cardiac gene therapy.

Authors:  Lijun Qian; Barsha Thapa; Jian Hong; Yanmei Zhang; Menglin Zhu; Ming Chu; Jing Yao; Di Xu
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

5.  A magnetic nanoparticle stabilized gas containing emulsion for multimodal imaging and triggered drug release.

Authors:  Wei Guo; Diancheng Li; Jia-an Zhu; Xiaohui Wei; Weiwei Men; Dazhi Yin; Mingxia Fan; Yuhong Xu
Journal:  Pharm Res       Date:  2014-04-10       Impact factor: 4.200

Review 6.  Ultrasound-induced biophysical effects in controlled drug delivery.

Authors:  Lulu Zhang; Zhuohua Lin; Lan Zeng; Fan Zhang; Lihong Sun; Suhui Sun; Ping Wang; Menghong Xu; Jinxia Zhang; Xiaolong Liang; Huiyu Ge
Journal:  Sci China Life Sci       Date:  2021-08-25       Impact factor: 6.038

7.  Activation of microbubbles by low-level therapeutic ultrasound enhances the antitumor effects of doxorubicin.

Authors:  Shuang Yang; Pan Wang; Xiaobing Wang; Xiaomin Su; Quanhong Liu
Journal:  Eur Radiol       Date:  2014-08-06       Impact factor: 5.315

8.  General Characteristics of Microbubble-Adenovirus Vectors Carrying Genes.

Authors:  Lingjie Yang; Juan Ma; Lina Guan; Yuming Mu
Journal:  Cell Mol Bioeng       Date:  2020-11-30       Impact factor: 2.321

9.  Gemcitabine-loaded microbubble system for ultrasound imaging and therapy.

Authors:  Lauren J Delaney; John R Eisenbrey; David Brown; Jonathan R Brody; Masaya Jimbo; Brian E Oeffinger; Maria Stanczak; Flemming Forsberg; Ji-Bin Liu; Margaret A Wheatley
Journal:  Acta Biomater       Date:  2021-05-31       Impact factor: 10.633

10.  Theranostic mRNA-loaded microbubbles in the lymphatics of dogs: implications for drug delivery.

Authors:  Heleen Dewitte; Katrien Vanderperren; Hendrik Haers; Emmelie Stock; Luc Duchateau; Myriam Hesta; Jimmy H Saunders; Stefaan C De Smedt; Ine Lentacker
Journal:  Theranostics       Date:  2015-01-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.